A blog article by Ashlie Reker Ph.D.
IND directed research must adhere to strict requirements for tracking and recording complex statistical, sample, and animal data. These specifications lend a greater degree of oversight, thereby improving accuracy and confidence in the final results of critical in vivo testing. The interplay between metadata tracking, drug discovery software, and in vivo research is critical to the future of countless patients and the pharmaceutical and healthcare industries. Optimizing this process by using a state of the art database system can dramatically improve efficiency while evaluating and managing complex data thereby reducing time to FDA approval.
